Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

CUSIP: 61023L207

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
6,743,758
Total 13F shares
5,525,394
Share change
+1,189,049
Total reported value
$360,692,606
Price per share
$65.30
Number of holders
73
Value change
+$75,159,494
Number of buys
55
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 61023L207?
CUSIP 61023L207 identifies MNPR - Monopar Therapeutics - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR) as of Q4 2025

As of 31 Dec 2025, Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,525,394 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., Saturn V Capital Management LP, VANGUARD GROUP INC, BlackRock, Inc., ADAR1 Capital Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, Siren, L.L.C., and DEERFIELD MANAGEMENT COMPANY, L.P.. This page lists 73 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.